作者: Sujatha Buddhe , Wei Du , Thomas L’Ecuyer
DOI: 10.1111/J.1399-3046.2012.01678.X
关键词:
摘要: Controversy exists over whether PHTN in heart transplant candidates increases post-transplant mortality. We performed analysis of data reported to UNOS for children who underwent primary transplantation cardiomyopathy from January 1994 June 2010. Patients were divided into two groups depending on their pre-transplant TPG: no-PHTN (TPG £ 12 mmHg) and >12 mm Hg). A total 6139 whom 2456 (40%) cardiomyopathies; 1322 (54%) these had catheteri- zation available. The group (mean TPG 19.5 ± 8.6) 312 patients 6.7 4.0) 1010. Mortality at one month (4.5% vs. 2.3%) three months (6.1% 3.1%) post- was significantly higher the than with an odds ratio 2 (p < 0.05). There no significant effect early mortality <1 yr age. sig- nificant improvement survival transplants after compared before 2003 despite availability pulmonary dilators. Pre-transplant post-trans- plant pediatric above has been outcome this last seven yr.